GUD (GUD) News
Track canonical SquawkNews coverage tagged to GUD, GUD. This hub brings together deduplicated headlines about nasdaqgs, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Knight Therapeutics receives Colombia regulatory approval for Tavalisse
Knight Therapeutics said regulatory approval was granted for Tavalisse® in Colombia.
EQUITY | Sep 01, 2026, 10:04 PM UTC
L
Knight Therapeutics files supplemental Brazil submission for Minjuvi
Knight Therapeutics announced a supplemental regulatory submission for Minjuvi in Brazil.
EQUITY | Aug 27, 2026, 10:07 PM UTC